Last update 10 Dec 2024

AC-591

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms
AC 591, AC-591, AC591
Target-
Mechanism-
Therapeutic Areas
NeoplasmsNervous System Diseases
Active Indication
AdenomaPeripheral Nervous System Diseases
Inactive Indication-
Originator Organization
Jiangsu Province Hospital of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine
Active Organization
Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd.Jiangsu Province Hospital of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese MedicineNanjing Zhongshan Pharmaceutical Co. Ltd.Nanjing Zhongshan Pharmaceutical Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with AC-591
NCT06722950 / Not yet recruitingPhase 2
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy
CTR20243618 / Not yet recruitingPhase 2
AC591颗粒预防奥沙利铂化疗引起的外周神经病变的随机、双盲、安慰剂平行对照、多中心、Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter, phase II clinical study of AC591 granules in preventing peripheral neuropathy induced by oxaliplatin chemotherapy
100 Clinical Results associated with AC-591
Login to view more data
100 Translational Medicine associated with AC-591
Login to view more data
100 Patents (Medical) associated with AC-591
Login to view more data
100 Deals associated with AC-591
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AdenomaPhase 2-
Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd.
01 Dec 2024
Peripheral Nervous System DiseasesPhase 2
CN
Jiangsu Province Hospital of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine
14 Oct 2024
Peripheral Nervous System DiseasesPhase 2
CN
Nanjing Zhongshan Pharmaceutical Co. Ltd.Nanjing Zhongshan Pharmaceutical Co. Ltd.
14 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free